Vimarsana
Biggest News Aggregation in the World

Solvent Interaction Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Solvent Interaction Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Solvent Interaction Analysis Today - Breaking & Trending Today

Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform - Vimarsana News

Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform

CLEVELAND--(BUSINESS WIRE)--Jan 17, 2024--

Cleveland Diagnostics Closes $75M Financing - Vimarsana News

Cleveland Diagnostics Closes $75M Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Cleveland Diagnostics Opens New Facility Amid Growing Demand for IsoPSA® Test - Vimarsana News

Cleveland Diagnostics Opens New Facility Amid Growing Demand for IsoPSA® Test

CLEVELAND--(BUSINESS WIRE)--Jun 28, 2023--

Cleveland Diagnostics Announces Inclusion of IsoPSA® in National Comprehensive Cancer Network® Guide - Vimarsana News

Cleveland Diagnostics Announces Inclusion of IsoPSA® in National Comprehensive Cancer Network® Guide

NCCN® Guidelines now include IsoPSA to further define the probability of high-grade prostate cancerCLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today that its prostate cancer t...

Cleveland Diagnostics, Inc. Raises Over $19 Million in Financing - Vimarsana News

Cleveland Diagnostics, Inc. Raises Over $19 Million in Financing

Posted on 196 Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today that it has closed a Series D round of $17.4 million. The round was led by LYFE Capital, with participation from existing investors including Cleveland Clinic and others. Following the close of the round, the company received a term sheet for a $2M convertible note, expected to close shortly. Funds raised will be used to expand commercialization of IsoPSAâ€...